|
|
 |
|
XNPT: Xenoport Inc - Stock News |
Enter Ticker:
|
|
| Nov 19, 2009 |
Stock research report available on XenoPort (NASDAQ:XNPT) from SmarTrend Analytics |
| Nov 19, 2009 |
XNPT: To Receive $5M Milestone from Astellas re NDA Filing in Japan |
| Nov 19, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: XNPT, SMSC |
| Nov 19, 2009 |
Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome |
| Nov 10, 2009 |
XenoPort Down 10.6% Since SmarTrend's Sell Recommendation |
| Nov 09, 2009 |
BiomedReports: News and FDA Updates for Quigley (Nasdaq:QGLY), GlaxoSmithKline (NYSE:GSK), XenoPort (Nasdaq:XNPT) |
| Nov 04, 2009 |
XenoPort Down 13.4% Since SmarTrend's Sell Recommendation |
| Nov 03, 2009 |
XenoPort Reports Third Quarter Financial Results |
| Oct 30, 2009 |
BiomedReports: News and FDA Updates for Allergan (NYSE:AGN), Medidata (Nasdaq: MDSO), XenoPort (Nasdaq:XNPT), Celldex (NASDAQ:CLDX) |
| Oct 30, 2009 |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 29, 2009 : TAYC, SBUX, XNPT and KITD |
| Oct 29, 2009 |
XenoPort to Release Third Quarter Financial Results on November 3, 2009 |
| Oct 28, 2009 |
XenoPort Down 6.2% Since SmarTrend's Sell Recommendation |
| Oct 22, 2009 |
XenoPort Begins Phase 2b Clinical Trial of Arbaclofen Placarbil |
| Oct 19, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: XNPT, SUPG |
| Oct 19, 2009 |
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease |
| |
| ZACKS COMMENTARY FOR XNPT |
| Nov 10, 2009 | Zacks Equity Research: Report for XNPT | | Jun 17, 2009 | Zacks Blog: XenoPort’s Potential Blockbuster | | May 06, 2009 | Zacks Blog: XenoPort: Long-Term Upside | | Feb 19, 2009 | Zacks Blog: Zacks Industry Rank Analysis Highlights: Myriad Genetics, Inc., Sangamo Biosciences, Inc., ZymoGenetics, Inc., Cytokinetics, Inc. and Xenoport Inc. | | Feb 18, 2009 | Zacks Industry Rank Analysis: Biotechs: A Trading Opportunity? |
|
|
Sponsored Links 
-0.15